Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Read now
Bianca Raffaelli, Heike Israel, Lars Neeb & Uwe Reuter. (2017) The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opinion on Pharmacotherapy 18:13, pages 1409-1415.
Read now
Read now
Matilde Capi, Fernando de Andrés, Luana Lionetto, Giovanna Gentile, Fabiola Cipolla, Andrea Negro, Marina Borro, Paolo Martelletti & Martina Curto. (2017) Lasmiditan for the treatment of migraine. Expert Opinion on Investigational Drugs 26:2, pages 227-234.
Read now
Read now
Maria Adele Giamberardino & Paolo Martelletti. (2015) Emerging drugs for migraine treatment. Expert Opinion on Emerging Drugs 20:1, pages 137-147.
Read now
Read now
Articles from other publishers (15)
Kevin A. Hurtado, Jaroslav Janda & Rick G. Schnellmann. (2023) Lasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis. American Journal of Physiology-Renal Physiology 324:1, pages F56-F63.
Crossref
Crossref
Giovanna Viticchi, Lorenzo Falsetti, Mauro Silvestrini & Marco Bartolini. (2022) Ditans: a new prospective for the therapy of migraine attack?. Neurological Sciences 43:9, pages 5709-5716.
Crossref
Crossref
Eduardo Rivera-Mancilla & Antoinette MaassenVanDenBrink. 2022. Novel Synthetic Drugs in Migraine. Novel Synthetic Drugs in Migraine
1
17
.
Farzin Zobdeh, Aziza Kraiem, Misty M. Attwood, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth & Jessica Mwinyi. (2021) Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. British Journal of Pharmacology 178:23, pages 4588-4607.
Crossref
Crossref
Ping Gu, Cheng Chen, Qian Wu, Changhong Dong, Teng Wang, Qi Wan & Xin Dong. (2021) The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis. BioMed Research International 2021, pages 1-14.
Crossref
Crossref
Anna Ferrari & Cecilia Rustichelli. (2021) Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review. Clinical Therapeutics 43:4, pages 654-670.
Crossref
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Crossref
Amanda E. Macone & Michael D. Perloff. (2020) Lasmiditan: Its Development and Potential Use. Clinical Pharmacology in Drug Development 9:3, pages 292-296.
Crossref
Crossref
Pin-Chung Huang, Fu-Chi Yang, Ching-Mao Chang & Chun-Pai Yang. 2020. Update on Emerging Treatments for Migraine. Update on Emerging Treatments for Migraine
99
121
.
Thien Phu Do, Song Guo & Messoud Ashina. (2019) Therapeutic novelties in migraine: new drugs, new hope?. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Yusuke Ishida, Yusuke Sugiura, Takuya Magome, Takefumi Kamakura, Yasumitsu Takimoto, Yukiko Hanada, Kazuki Kitayama, Yukiko Nakamura, Shoichi Shimada, Nobuo Ohta, Rumi Naono-Nakayama & Keiju Kamijo. (2019) Expression Analysis of Serotonin Receptors, Serotonin Transporter and l-Amino Acid Decarboxylase in the Mouse Sphenopalatine Ganglion by RT-PCR, Northern Blot Analysis and In Situ Hybridization. Neuroscience 411, pages 23-36.
Crossref
Crossref
Marta Vila-Pueyo. (2018) Targeted 5-HT1F Therapies for Migraine. Neurotherapeutics 15:2, pages 291-303.
Crossref
Crossref
Claudia Francesca Gasparini, Robert Anthony Smith & Lyn Robyn Griffiths. (2017) Genetic and biochemical changes of the serotonergic system in migraine pathobiology. The Journal of Headache and Pain 18:1.
Crossref
Crossref
Kelsey Merison & Howard Jacobs. (2016) Diagnosis and Treatment of Childhood Migraine. Current Treatment Options in Neurology 18:11.
Crossref
Crossref
Kevin Hurtado, Jaroslav Janda & Rick G. Schnellmann. (2022) Lasmiditan Promotes Recovery of Renal Function Through Mitochondrial Biogenesis. SSRN Electronic Journal.
Crossref
Crossref